It can assess patients’ suitability for Amgen’s colorectal cancer drug, Vectibix. Canadian regulatory authorities approved DxS’ TheraScreen K-RAS Mutation Kit for use as a diagnostic for anti-EGFR ...
Hosted on MSN
Health Ministry said to flag error in genetic test kit detecting rare mutation, reread results
The Health Ministry’s discovery of a malfunction in test kits used to detect a genetic mutation especially common among Ashkenazi Jews has reportedly led to the formation of a special review committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback